Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring
- 27 March 2007
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 6 (5) , 431-441
- https://doi.org/10.1016/s1474-4422(07)70078-9
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Published by Wiley ,2006
- Natalizumab and PMLNature Neuroscience, 2005
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's DiseaseNew England Journal of Medicine, 2005
- Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphomaAmerican Journal of Hematology, 2001
- Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patientsAIDS, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Case Report Simultaneous fungal and viral infection of the central nervous systemThe Lancet Healthy Longevity, 1978
- PROGRESSIVE MULTIFOCAL LEUKO-ENCEPHALOPATHYBrain, 1958